- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 96 x FMT: FORMIC ACID(Non-functional Binders)
FMT.2: 3 residues within 4Å:- Chain A: Q.398, M.449, R.453
Ligand excluded by PLIPFMT.3: 8 residues within 4Å:- Chain A: R.358, R.359, F.360
- Chain F: P.247, G.248, V.407, A.409, R.461
Ligand excluded by PLIPFMT.4: 5 residues within 4Å:- Chain A: P.137, Y.138, A.142, R.144
- Ligands: FMT.13
Ligand excluded by PLIPFMT.5: 6 residues within 4Å:- Chain A: R.25, K.60, G.61, V.99, I.100, S.101
Ligand excluded by PLIPFMT.6: 8 residues within 4Å:- Chain A: R.86, R.89, N.90, V.94, R.95, L.96, N.260, E.261
Ligand excluded by PLIPFMT.7: 6 residues within 4Å:- Chain A: H.384, M.388, C.415, S.416
- Chain E: G.234, V.235
Ligand excluded by PLIPFMT.9: 6 residues within 4Å:- Chain A: R.22, P.23, R.25, L.26, K.45, E.80
Ligand excluded by PLIPFMT.10: 4 residues within 4Å:- Chain A: P.44, K.45, E.48, D.79
Ligand excluded by PLIPFMT.11: 7 residues within 4Å:- Chain A: N.36, V.87, N.91, P.145, I.146, D.150, F.152
Ligand excluded by PLIPFMT.12: 9 residues within 4Å:- Chain A: I.274, M.275, K.277, L.278, A.279, S.282, V.320, I.324
- Chain E: R.323
Ligand excluded by PLIPFMT.13: 5 residues within 4Å:- Chain A: P.137, Y.138, V.154, R.155
- Ligands: FMT.4
Ligand excluded by PLIPFMT.14: 2 residues within 4Å:- Chain A: K.62, K.63
Ligand excluded by PLIPFMT.15: 3 residues within 4Å:- Chain A: R.256, F.266, L.268
Ligand excluded by PLIPFMT.16: 3 residues within 4Å:- Chain A: K.63, R.93, E.195
Ligand excluded by PLIPFMT.17: 3 residues within 4Å:- Chain A: V.108, K.109, Y.110
Ligand excluded by PLIPFMT.19: 6 residues within 4Å:- Chain A: R.155, G.156, K.386, N.387, M.388, K.389
Ligand excluded by PLIPFMT.22: 3 residues within 4Å:- Chain B: Q.398, M.449, R.453
Ligand excluded by PLIPFMT.23: 8 residues within 4Å:- Chain B: R.358, R.359, F.360
- Chain D: P.247, G.248, V.407, A.409, R.461
Ligand excluded by PLIPFMT.24: 5 residues within 4Å:- Chain B: P.137, Y.138, A.142, R.144
- Ligands: FMT.33
Ligand excluded by PLIPFMT.25: 6 residues within 4Å:- Chain B: R.25, K.60, G.61, V.99, I.100, S.101
Ligand excluded by PLIPFMT.26: 8 residues within 4Å:- Chain B: R.86, R.89, N.90, V.94, R.95, L.96, N.260, E.261
Ligand excluded by PLIPFMT.27: 6 residues within 4Å:- Chain B: H.384, M.388, C.415, S.416
- Chain F: G.234, V.235
Ligand excluded by PLIPFMT.29: 6 residues within 4Å:- Chain B: R.22, P.23, R.25, L.26, K.45, E.80
Ligand excluded by PLIPFMT.30: 4 residues within 4Å:- Chain B: P.44, K.45, E.48, D.79
Ligand excluded by PLIPFMT.31: 7 residues within 4Å:- Chain B: N.36, V.87, N.91, P.145, I.146, D.150, F.152
Ligand excluded by PLIPFMT.32: 9 residues within 4Å:- Chain B: I.274, M.275, K.277, L.278, A.279, S.282, V.320, I.324
- Chain F: R.323
Ligand excluded by PLIPFMT.33: 5 residues within 4Å:- Chain B: P.137, Y.138, V.154, R.155
- Ligands: FMT.24
Ligand excluded by PLIPFMT.34: 2 residues within 4Å:- Chain B: K.62, K.63
Ligand excluded by PLIPFMT.35: 3 residues within 4Å:- Chain B: R.256, F.266, L.268
Ligand excluded by PLIPFMT.36: 3 residues within 4Å:- Chain B: K.63, R.93, E.195
Ligand excluded by PLIPFMT.37: 3 residues within 4Å:- Chain B: V.108, K.109, Y.110
Ligand excluded by PLIPFMT.39: 6 residues within 4Å:- Chain B: R.155, G.156, K.386, N.387, M.388, K.389
Ligand excluded by PLIPFMT.42: 3 residues within 4Å:- Chain C: Q.398, M.449, R.453
Ligand excluded by PLIPFMT.43: 8 residues within 4Å:- Chain C: R.358, R.359, F.360
- Chain E: P.247, G.248, V.407, A.409, R.461
Ligand excluded by PLIPFMT.44: 5 residues within 4Å:- Chain C: P.137, Y.138, A.142, R.144
- Ligands: FMT.53
Ligand excluded by PLIPFMT.45: 6 residues within 4Å:- Chain C: R.25, K.60, G.61, V.99, I.100, S.101
Ligand excluded by PLIPFMT.46: 8 residues within 4Å:- Chain C: R.86, R.89, N.90, V.94, R.95, L.96, N.260, E.261
Ligand excluded by PLIPFMT.47: 6 residues within 4Å:- Chain C: H.384, M.388, C.415, S.416
- Chain D: G.234, V.235
Ligand excluded by PLIPFMT.49: 6 residues within 4Å:- Chain C: R.22, P.23, R.25, L.26, K.45, E.80
Ligand excluded by PLIPFMT.50: 4 residues within 4Å:- Chain C: P.44, K.45, E.48, D.79
Ligand excluded by PLIPFMT.51: 7 residues within 4Å:- Chain C: N.36, V.87, N.91, P.145, I.146, D.150, F.152
Ligand excluded by PLIPFMT.52: 9 residues within 4Å:- Chain C: I.274, M.275, K.277, L.278, A.279, S.282, V.320, I.324
- Chain D: R.323
Ligand excluded by PLIPFMT.53: 5 residues within 4Å:- Chain C: P.137, Y.138, V.154, R.155
- Ligands: FMT.44
Ligand excluded by PLIPFMT.54: 2 residues within 4Å:- Chain C: K.62, K.63
Ligand excluded by PLIPFMT.55: 3 residues within 4Å:- Chain C: R.256, F.266, L.268
Ligand excluded by PLIPFMT.56: 3 residues within 4Å:- Chain C: K.63, R.93, E.195
Ligand excluded by PLIPFMT.57: 3 residues within 4Å:- Chain C: V.108, K.109, Y.110
Ligand excluded by PLIPFMT.59: 6 residues within 4Å:- Chain C: R.155, G.156, K.386, N.387, M.388, K.389
Ligand excluded by PLIPFMT.62: 3 residues within 4Å:- Chain D: Q.398, M.449, R.453
Ligand excluded by PLIPFMT.63: 8 residues within 4Å:- Chain C: P.247, G.248, V.407, A.409, R.461
- Chain D: R.358, R.359, F.360
Ligand excluded by PLIPFMT.64: 5 residues within 4Å:- Chain D: P.137, Y.138, A.142, R.144
- Ligands: FMT.73
Ligand excluded by PLIPFMT.65: 6 residues within 4Å:- Chain D: R.25, K.60, G.61, V.99, I.100, S.101
Ligand excluded by PLIPFMT.66: 8 residues within 4Å:- Chain D: R.86, R.89, N.90, V.94, R.95, L.96, N.260, E.261
Ligand excluded by PLIPFMT.67: 6 residues within 4Å:- Chain B: G.234, V.235
- Chain D: H.384, M.388, C.415, S.416
Ligand excluded by PLIPFMT.69: 6 residues within 4Å:- Chain D: R.22, P.23, R.25, L.26, K.45, E.80
Ligand excluded by PLIPFMT.70: 4 residues within 4Å:- Chain D: P.44, K.45, E.48, D.79
Ligand excluded by PLIPFMT.71: 7 residues within 4Å:- Chain D: N.36, V.87, N.91, P.145, I.146, D.150, F.152
Ligand excluded by PLIPFMT.72: 9 residues within 4Å:- Chain B: R.323
- Chain D: I.274, M.275, K.277, L.278, A.279, S.282, V.320, I.324
Ligand excluded by PLIPFMT.73: 5 residues within 4Å:- Chain D: P.137, Y.138, V.154, R.155
- Ligands: FMT.64
Ligand excluded by PLIPFMT.74: 2 residues within 4Å:- Chain D: K.62, K.63
Ligand excluded by PLIPFMT.75: 3 residues within 4Å:- Chain D: R.256, F.266, L.268
Ligand excluded by PLIPFMT.76: 3 residues within 4Å:- Chain D: K.63, R.93, E.195
Ligand excluded by PLIPFMT.77: 3 residues within 4Å:- Chain D: V.108, K.109, Y.110
Ligand excluded by PLIPFMT.79: 6 residues within 4Å:- Chain D: R.155, G.156, K.386, N.387, M.388, K.389
Ligand excluded by PLIPFMT.82: 3 residues within 4Å:- Chain E: Q.398, M.449, R.453
Ligand excluded by PLIPFMT.83: 8 residues within 4Å:- Chain A: P.247, G.248, V.407, A.409, R.461
- Chain E: R.358, R.359, F.360
Ligand excluded by PLIPFMT.84: 5 residues within 4Å:- Chain E: P.137, Y.138, A.142, R.144
- Ligands: FMT.93
Ligand excluded by PLIPFMT.85: 6 residues within 4Å:- Chain E: R.25, K.60, G.61, V.99, I.100, S.101
Ligand excluded by PLIPFMT.86: 8 residues within 4Å:- Chain E: R.86, R.89, N.90, V.94, R.95, L.96, N.260, E.261
Ligand excluded by PLIPFMT.87: 6 residues within 4Å:- Chain C: G.234, V.235
- Chain E: H.384, M.388, C.415, S.416
Ligand excluded by PLIPFMT.89: 6 residues within 4Å:- Chain E: R.22, P.23, R.25, L.26, K.45, E.80
Ligand excluded by PLIPFMT.90: 4 residues within 4Å:- Chain E: P.44, K.45, E.48, D.79
Ligand excluded by PLIPFMT.91: 7 residues within 4Å:- Chain E: N.36, V.87, N.91, P.145, I.146, D.150, F.152
Ligand excluded by PLIPFMT.92: 9 residues within 4Å:- Chain C: R.323
- Chain E: I.274, M.275, K.277, L.278, A.279, S.282, V.320, I.324
Ligand excluded by PLIPFMT.93: 5 residues within 4Å:- Chain E: P.137, Y.138, V.154, R.155
- Ligands: FMT.84
Ligand excluded by PLIPFMT.94: 2 residues within 4Å:- Chain E: K.62, K.63
Ligand excluded by PLIPFMT.95: 3 residues within 4Å:- Chain E: R.256, F.266, L.268
Ligand excluded by PLIPFMT.96: 3 residues within 4Å:- Chain E: K.63, R.93, E.195
Ligand excluded by PLIPFMT.97: 3 residues within 4Å:- Chain E: V.108, K.109, Y.110
Ligand excluded by PLIPFMT.99: 6 residues within 4Å:- Chain E: R.155, G.156, K.386, N.387, M.388, K.389
Ligand excluded by PLIPFMT.102: 3 residues within 4Å:- Chain F: Q.398, M.449, R.453
Ligand excluded by PLIPFMT.103: 8 residues within 4Å:- Chain B: P.247, G.248, V.407, A.409, R.461
- Chain F: R.358, R.359, F.360
Ligand excluded by PLIPFMT.104: 5 residues within 4Å:- Chain F: P.137, Y.138, A.142, R.144
- Ligands: FMT.113
Ligand excluded by PLIPFMT.105: 6 residues within 4Å:- Chain F: R.25, K.60, G.61, V.99, I.100, S.101
Ligand excluded by PLIPFMT.106: 8 residues within 4Å:- Chain F: R.86, R.89, N.90, V.94, R.95, L.96, N.260, E.261
Ligand excluded by PLIPFMT.107: 6 residues within 4Å:- Chain A: G.234, V.235
- Chain F: H.384, M.388, C.415, S.416
Ligand excluded by PLIPFMT.109: 6 residues within 4Å:- Chain F: R.22, P.23, R.25, L.26, K.45, E.80
Ligand excluded by PLIPFMT.110: 4 residues within 4Å:- Chain F: P.44, K.45, E.48, D.79
Ligand excluded by PLIPFMT.111: 7 residues within 4Å:- Chain F: N.36, V.87, N.91, P.145, I.146, D.150, F.152
Ligand excluded by PLIPFMT.112: 9 residues within 4Å:- Chain A: R.323
- Chain F: I.274, M.275, K.277, L.278, A.279, S.282, V.320, I.324
Ligand excluded by PLIPFMT.113: 5 residues within 4Å:- Chain F: P.137, Y.138, V.154, R.155
- Ligands: FMT.104
Ligand excluded by PLIPFMT.114: 2 residues within 4Å:- Chain F: K.62, K.63
Ligand excluded by PLIPFMT.115: 3 residues within 4Å:- Chain F: R.256, F.266, L.268
Ligand excluded by PLIPFMT.116: 3 residues within 4Å:- Chain F: K.63, R.93, E.195
Ligand excluded by PLIPFMT.117: 3 residues within 4Å:- Chain F: V.108, K.109, Y.110
Ligand excluded by PLIPFMT.119: 6 residues within 4Å:- Chain F: R.155, G.156, K.386, N.387, M.388, K.389
Ligand excluded by PLIP- 6 x 6LY: (1S)-2-amino-1-(4-bromophenyl)ethan-1-ol(Non-covalent)
6LY.8: 8 residues within 4Å:- Chain A: R.113, I.114, H.115, E.167, T.168, D.169, H.183, E.185
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:H.115, A:H.183
- Hydrogen bonds: A:H.183, A:E.185, A:E.185
- pi-Stacking: A:H.115, A:H.183
- Halogen bonds: A:R.113
6LY.28: 8 residues within 4Å:- Chain B: R.113, I.114, H.115, E.167, T.168, D.169, H.183, E.185
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:H.115, B:H.183
- Hydrogen bonds: B:H.183, B:E.185, B:E.185
- pi-Stacking: B:H.115, B:H.183
- Halogen bonds: B:R.113
6LY.48: 8 residues within 4Å:- Chain C: R.113, I.114, H.115, E.167, T.168, D.169, H.183, E.185
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:H.115, C:H.183
- Hydrogen bonds: C:H.183, C:E.185, C:E.185
- pi-Stacking: C:H.115, C:H.183
- Halogen bonds: C:R.113
6LY.68: 8 residues within 4Å:- Chain D: R.113, I.114, H.115, E.167, T.168, D.169, H.183, E.185
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:H.115, D:H.183
- Hydrogen bonds: D:H.183, D:E.185, D:E.185
- pi-Stacking: D:H.115, D:H.183
- Halogen bonds: D:R.113
6LY.88: 8 residues within 4Å:- Chain E: R.113, I.114, H.115, E.167, T.168, D.169, H.183, E.185
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:H.115, E:H.183
- Hydrogen bonds: E:H.183, E:E.185, E:E.185
- pi-Stacking: E:H.115, E:H.183
- Halogen bonds: E:R.113
6LY.108: 8 residues within 4Å:- Chain F: R.113, I.114, H.115, E.167, T.168, D.169, H.183, E.185
8 PLIP interactions:8 interactions with chain F- Hydrophobic interactions: F:H.115, F:H.183
- Hydrogen bonds: F:H.183, F:E.185, F:E.185
- pi-Stacking: F:H.115, F:H.183
- Halogen bonds: F:R.113
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.18: 11 residues within 4Å:- Chain A: P.223, F.230, P.237, R.239, L.335, K.336, R.338, A.339, H.340, V.341, I.342
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.340, A:V.341
PEG.38: 11 residues within 4Å:- Chain B: P.223, F.230, P.237, R.239, L.335, K.336, R.338, A.339, H.340, V.341, I.342
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.340, B:V.341
PEG.58: 11 residues within 4Å:- Chain C: P.223, F.230, P.237, R.239, L.335, K.336, R.338, A.339, H.340, V.341, I.342
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:H.340, C:V.341
PEG.78: 11 residues within 4Å:- Chain D: P.223, F.230, P.237, R.239, L.335, K.336, R.338, A.339, H.340, V.341, I.342
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:H.340, D:V.341
PEG.98: 11 residues within 4Å:- Chain E: P.223, F.230, P.237, R.239, L.335, K.336, R.338, A.339, H.340, V.341, I.342
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:H.340, E:V.341
PEG.118: 11 residues within 4Å:- Chain F: P.223, F.230, P.237, R.239, L.335, K.336, R.338, A.339, H.340, V.341, I.342
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:H.340, F:V.341
- 6 x NA: SODIUM ION(Non-functional Binders)
NA.20: 5 residues within 4Å:- Chain A: R.191, E.192, E.194, E.195, E.196
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.196, A:E.196
- Water bridges: A:E.196
NA.40: 5 residues within 4Å:- Chain B: R.191, E.192, E.194, E.195, E.196
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.194, B:E.196
- Water bridges: B:E.196
NA.60: 5 residues within 4Å:- Chain C: R.191, E.192, E.194, E.195, E.196
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:E.194, C:E.196
- Water bridges: C:E.196
NA.80: 5 residues within 4Å:- Chain D: R.191, E.192, E.194, E.195, E.196
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:E.196, D:E.196
- Water bridges: D:E.196
NA.100: 5 residues within 4Å:- Chain E: R.191, E.192, E.194, E.195, E.196
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:E.196, E:E.196
- Water bridges: E:E.196
NA.120: 5 residues within 4Å:- Chain F: R.191, E.192, E.194, E.195, E.196
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:R.191, F:E.196
- Water bridges: F:E.196
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bothe, S. et al., Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97. Commun Chem (2022)
- Release Date
- 2022-12-14
- Peptides
- Transitional endoplasmic reticulum ATPase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 96 x FMT: FORMIC ACID(Non-functional Binders)
- 6 x 6LY: (1S)-2-amino-1-(4-bromophenyl)ethan-1-ol(Non-covalent)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bothe, S. et al., Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97. Commun Chem (2022)
- Release Date
- 2022-12-14
- Peptides
- Transitional endoplasmic reticulum ATPase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A